Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Overall, the one-time LDCT diagnostic performance in the non-risk-based screening population had a sensitivity of 96.6%, a ...

"Overall, hydroxyurea remained effective over time in these children," said Dr. George. "However, one important takeaway from this study is that improvements in hemoglobin concentration—or ...

who was not involved in the new study. Effective treatments for gonorrhea have become increasingly limited in recent years ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...

"Given that participants had not yet reached a weight plateau at the time the study ended ... refrigerated," Aronne told CBS News. "It's as effective as one of the injectable drugs we have ...

When grandma and grandpa take over childcare duties, nearly half the time is spent staring at screens, according to new ...

who was not involved in the new study. Effective treatments for gonorrhea have become increasingly limited in recent years due to the global rise of antimicrobial resistance in Neisseria ...

Professor Peter Coventry, Director of the University's Mental Health and Addiction Research Group, said, "We have known for some time that nature ... participants in our study, demonstrated ...

Deal pricing and availability subject to change after time of publication. Lindsey Ellefson is Lifehacker’s Features Editor. She currently covers study and productivity hacks, as well as ...